The association of mediastinal germ cell tumors (GCTs) and hematological malignancy has been documented for more than 20 years. 1, 2 This rare association is known to be extremely refractory to modern therapy. Here we report the successful treatment of a boy with Klinefelter's syndrome complicated by this disease.
A 13-year-old boy with no significant past medical history was referred to our hospital due to persistent fever and nasal bleeding. Physical examination demonstrated extensive ecchymosis, hepatosplenomegaly and reduced breath sounds on the right chest. Chest X-ray showed an abnormal mass in the anterior mediastinum ( Figure 1 ). The mass contained dense calcification, which was suggestive of a teratoma. Complete blood count showed a white blood cell count of 8.0 Â 10 9 /l with 21% blasts, hemoglobin of 9.8 g per 100 ml, and platelets of 33 Â 10 9 /l. Blood chemistry showed a normal level of aspartate and alanine aminotransferase and elevated lactate dehydrogenase level of 2253 IU/l. Serum a-fetoprotein (AFP) and human chorionic gonadotropin (hCG) were elevated to 995 ng/ml (normal o15 ng/ml) and 15.3 mIU/ml (normal o0.5 mIU/ ml), respectively. Bone marrow (BM) aspiration demonstrated 26.4% leukemic blast cells that were morphologically acute myeloid leukemia (AML (M7)). Fluorescence-activated cell sorting analysis showed that these blasts were positive for CD41a and CD61. Computed tomography and magnetic resonance imaging of chest showed a tumor measuring 11 Â 8 Â 7 cm in the anterior right mediastinum, which demonstrated a complex pattern of signals. Fine needle biopsy of the anterior mediastinal mass was subsequently performed. Histological examination demonstrated neuroepithelial components with mature teratomatous tissue, indicating germ cell tumor. The patient had the characteristics of Klinefelter's syndrome including long extremities and gynecomastia. Chromosome analysis demonstrated 47, XXY, confirming the diagnosis. According to the cases reported to date, almost all cases of mediastinal GCT complicated by hematological malignancy have died of leukemia. Therefore, we decided to treat the leukemia first. The patient was treated with the AML99 protocol, 3 which consists of induction chemotherapy (cytarabine, etoposide and mitoxantrone) and five courses of intensive chemotherapy (high-dose cytarabine, etoposide, idarubicine and mitoxantrone). After induction chemotherapy, the patient achieved complete remission (CR). We added cisplatinum to each course of intensive chemotherapy to augment the antitumor effect against GCT. Intensive chemotherapy plus cisplatinum was administered every 4 weeks without significant toxicity other than severe pancytopenia. During chemotherapy, the size of the mediastinal tumor remained almost the same, while serum AFP and the hCG levels declined to nearnormal levels. About 7 months after the initiation of chemotherapy, the patient underwent cord blood transplantation (CBT), because there were no potential donors in either his relatives or the Japan Marrow Donor Program. The cord blood was serologically full matched, genetically mismatched in one of the HLA-DRB1 locus only in the graft-versus-host disease (GvHD) direction. The conditioning regimen consisted of 16 mg/m2 busulfan, 120 mg/m2 cyclophosphamide and 50 mg/kg etoposide. The transplanted cell dose was 2.25 Â 10 7 /kg (CD34 þ cells; 6 Â 10 4 /kg). For GvHD prophylaxis, cyclosporine (3 mg/kg per day) and short-term methotrexate (10 mg/kg on day 1 and 7 mg/kg on days 3 and 6) were administered. Mild engraftment syndrome was observed on day 12, which responded well to 1 mg/kg prednisolone. Engraftment of neutrophils was observed on day 20 (45 Â 10 8 /l), platelets on day 35 (420 Â 10 9 /l) and red blood cells on day 35 (reticulocytes 410%). Grade I GvHD (skin, stage 2) was observed about 4 weeks after transplantation, which responded well to the standard steroid therapy. BM aspiration at 1 month demonstrated complete chimerism of donor origin. On day 56, surgical removal of the mediastinal tumor was performed. The tumor measured 16 Â 14 Â 6 cm, consisted of fibrous tissue intermingled with mucous cysts, brain-like structure, teeth and hair. The tumor did not invade the adjacent organs but a small area of lung tissue was firmly attached to it. It was completely resected with adequate margins. Microscopic examination demonstrated atypical cells compatible with adenocarcinoma or choroid plexus carcinoma as well as mature tissues such as squamous epithelium, cartilage, bone, gut, brain and thyroid gland. These findings are compatible with a diagnosis of malignant teratoma with nongerminal malignant tumor (carcinoma). Although the patient developed respiratory failure due to pneumonia shortly after surgery, he recovered fully with antibiotic therapy and mechanical ventilation. He has now remained free from disease 3 1 2 years after the onset of disease. Cases of mediastinal GCT associated with hematological abnormalities have been reported since the 1980s. In 1990, Nichols et al. 4 described 16 cases of GCT, including two cases, which seemed to have Klinefelter's syndrome. All patients were relatively young males and had nonseminomatous mediastinal germ cell tumors. AML (M7) and malignant histiocytosis were the most common hematological abnormalities. In one patient, i(12p) isochromosome was identified in both the GCT and leukemic blasts. Woodruff et al. also identified i(12p) in both the mediastinal GCT and associated hematologic malignancy. Orazi et al. 6 reported hematopoietic precursors within the mediastinal GCT in patients with this association. With these observations, the hypothesis that the leukemic clone originates from GCTs has been suggested. Although histological examination did not demonstrate any hematopoiesis in GCT in our patient, chromosome analysis showed marked similarities between GCT cells and leukemic blasts (Table 1) , which supports this hypothesis. Considering previous findings that patients with this syndrome have an extremely poor prognosis due to leukemia, we administered chemotherapy before surgical removal of the mediastinal cell tumor. Some reports argue against intensive consolidation therapy for AML. 7, 8 However, in view of the fact that current protocols of major clinical trials for childhood AML contain consolidation therapy, and that four courses of bleomycin, etoposide and cisplatin are the standard therapy for extragonadal germ cell tumors, 9 we concluded that AML99, standard treatment for childhood AML in Japan, which involved the use of cisplatin, would be a reasonable combination. With this therapy, our patient achieved CR and stabilization of mediastinal GCT. The reports that allogeneic HSCT for childhood AML with a poor prognosis can be a powerful therapeutic modality 10, 11 and the efficacy of CBT for childhood AML in the first CR in Japan is as good as unrelated BM transplantation convinced us to undertake CBT using well-matched cord blood. Also, importantly, our patient did not experience severe GvHD, making surgery uncomplicated.
In summary, we present a therapeutic strategy for the successful management of mediastinal GCTs associated with hematological malignancy. Hopefully, this experience will contribute to improving the prognosis of this intractable disease. Table 1 Chromosomal analysis of germ cell tumor (GCT) and M7 Letter to the Editor
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